Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

by

Men with a particular genetic subtype of the steroid biosynthesis enzyme HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer, according to new Cleveland Clinic-led research published in Journal of Clinical Investigation.

Leave A Comment

Your email address will not be published. Required fields are marked *